DeepMed Research

Geistlich Pharma AG

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.geistlich-pharma.com

Clinical Trials

Chondro-Gide® Bilayer Collagen Membrane in Knee Cartilage Defect Repair

Not Applicable

Recruiting

Conditions: Cartilage Defects

Interventions: Procedure: Microfracture
Device: Chondro-Gide bilayer collagen membrane

First Posted Date: 2023-03-27

Last Posted Date: 2023-06-22

Lead Sponsor: Geistlich Pharma AG

Target Recruit Count: 140

Registration Number: NCT05785949

Locations: 🇨🇳
The Third Affiliated Hospital of Southern Medical University, Guangzhou, China
🇨🇳
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
🇨🇳
The Second Hospital of Jilin University, Changchun, China

and more 7 locations

AMIC vs. MFx in the Ankle

Not Applicable

Withdrawn

Conditions: Microfracture
Osteochondral Lesion of Talus
Chondral Defect

Interventions: Procedure: Microfracture (MFx)
Device: Chondro-Gide®

First Posted Date: 2023-02-23

Last Posted Date: 2024-03-18

Lead Sponsor: Geistlich Pharma AG

Registration Number: NCT05741983

Locations: 🇬🇧
Freeman Hospital, Newcastle upon Tyne, United Kingdom

Evaluation of Geistlich Fibro-Gide® in Comparison to CTG for the Treatment Around Implants

Not Applicable

Active, not recruiting

Conditions: Soft Tissue Defect

Interventions: Procedure: Soft tissue flap + Connective Tissue Graft
Device: Soft tissue flap + Geistlich Fibro-Gide®

First Posted Date: 2021-01-11

Last Posted Date: 2021-12-15

Lead Sponsor: Geistlich Pharma AG

Target Recruit Count: 60

Registration Number: NCT04703738

Locations: 🇺🇸
Regenerative Solutions, Fullerton, California, United States
🇺🇸
Periodontal and Dental Implant Surgical Specialist, Virginia Beach, Virginia, United States
🇺🇸
Santarelli Oral and Facial Surgery, Kenosha, Wisconsin, United States

and more 2 locations

Clinical Study of Chondro-Gide® for Large Chondral Lesions in the Knee

Not Applicable

Active, not recruiting

Conditions: Cartilage Injury
Cartilage Disease
Knee Injuries
Knee Discomfort

Interventions: Procedure: Microfracture
Device: Microfracture plus placement of Chondro-Gide® ACC

First Posted Date: 2020-09-03

Last Posted Date: 2025-05-04

Lead Sponsor: Geistlich Pharma AG

Target Recruit Count: 234

Registration Number: NCT04537013

Locations: 🇺🇸
The MORE Foundation, Phoenix, Arizona, United States
🇺🇸
Orthopaedic Foundation, Stamford, Connecticut, United States
🇺🇸
Emory Sports Medicine Complex, Johns Creek, Georgia, United States

and more 12 locations

Evaluation of Geistlich Fibro-Gide® + CAF in Comparison to CTG + CAF for the Treatment of Recession Defects at 6 Months

Not Applicable

Completed

Conditions: Gingival Recession

Interventions: Device: Geistlich Fibro-Gide
Procedure: Connective Tissue Graft (CTG

First Posted Date: 2020-02-07

Last Posted Date: 2021-08-10

Lead Sponsor: Geistlich Pharma AG

Target Recruit Count: 30

Registration Number: NCT04260152

Locations: 🇺🇸
Oral Health Specialists, Tacoma, Washington, United States
🇺🇸
Perio Health Professionals, Houston, Texas, United States
🇺🇸
Seven Lakes Periodontitis, Fenton, Michigan, United States

Trial to Evaluate Safety, Tolerability, Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis

Phase 2

Completed

Conditions: Periodontitis

Interventions: Drug: PerioSept(r)

First Posted Date: 2019-09-18

Last Posted Date: 2020-10-19

Lead Sponsor: Geistlich Pharma AG

Target Recruit Count: 12

Registration Number: NCT04093895

Locations: 🇺🇸
Perio Health Professionals, Houston, Texas, United States

Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine

Phase 1

Recruiting

Conditions: Pancreatic Cancer, Adult

Interventions: Drug: GP-2250

First Posted Date: 2019-02-26

Last Posted Date: 2024-02-28

Lead Sponsor: Geistlich Pharma AG

Target Recruit Count: 64

Registration Number: NCT03854110

Locations: 🇺🇸
University of Kansas Cancer Center, Fairway, Kansas, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Hoag Family Cancer Institute, Newport Beach, California, United States

and more 2 locations

Evidence For Fusion In Spine With Orthoss®

Recruiting

Conditions: Lumbar Spinal Stenosis
Lumbar Spondylolisthesis Involving L4-L5
Lumbar Disc Degeneration
Lumbar Spondylolisthesis Involving L5-S1

Interventions: Device: Orthoss

First Posted Date: 2019-02-25

Last Posted Date: 2023-03-01

Lead Sponsor: Geistlich Pharma AG

Target Recruit Count: 65

Registration Number: NCT03853356

Locations: 🇩🇪
Klinikum Magdeburg gGmbH, Magdeburg, Germany
🇩🇪
Universitätsklinikum Augsburg - Neurochirurgische Klinik und Poliklinik, Augsburg, Germany
🇩🇪
Universitätsklinikum Düsseldorf, Düsseldorf, Germany

Long-term Follow-up Observation After Surgical Treatment of Peri-implantitis in Multicenter Post Market Clinical Study

Completed

Conditions: Peri-implantitis

Interventions: Other: observational study

First Posted Date: 2018-12-14

Last Posted Date: 2019-08-28

Lead Sponsor: Geistlich Pharma AG

Target Recruit Count: 59

Registration Number: NCT03776097

Locations: 🇸🇪
Kristianstad University, Kristianstad, Sweden

A Randomized Controlled Trial Comparing Chondro-Gide® to Microfracture Alone for Treatment of Knee Cartilage Defects.

Phase 3

Completed

Conditions: Cartilage Injury
Osteochondritis Dissecans

Interventions: Procedure: Microfracture
Device: Chondro-Gide glued
Device: Chondro-Gide sutured

First Posted Date: 2016-12-15

Last Posted Date: 2017-02-23

Lead Sponsor: Geistlich Pharma AG

Target Recruit Count: 67

Registration Number: NCT02993510

Locations: 🇩🇪
Unfallklinik Hannover, Hanover, Germany
🇩🇪
Universitätsklinikum Freiburg, Freiburg, Germany
🇩🇪
Sportklinik Ravensburg, Ravensburg, Germany

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy